Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Atopic diseases

The hype and hope of new food allergy treatments

Food allergy treatment is undergoing a paradigm shift with new therapies emerging, including the recent FDA approval of omalizumab — but without evidence of disease modification and with uncertain quality-of-life improvement, it may not be a panacea for all.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Food allergen thresholds with omalizumab and placebo in the OUtMATCH study.

References

  1. Wood, R. A. et al. N. Engl. J. Med. 390, 889–899 (2024).

    Article  CAS  PubMed  Google Scholar 

  2. US Food and Drug Administration. FDA https://go.nature.com/3JgRn05 (16 February 2024).

  3. Hippocrates. Ancient Medicine (transl. Jones, W. H. S.) (G. P. Putnam, 1931).

  4. Schofield, A. Lancet 171, 716 (1908).

    Article  Google Scholar 

  5. The PALISADE Group of Clinical Investigators. N. Engl. J. Med. 379, 1991–2001 (2018).

    Article  Google Scholar 

  6. Palforzia. https://palforziarems.com/#Main/Home (accessed 26 March 2024).

  7. Australasian Society of Clinical Immunology and Allergy. https://go.nature.com/3TWewK7 (accessed 26 March 2024).

  8. Chu, D. K. et al. Lancet 393, 2222–2232 (2019).

    Article  CAS  PubMed  Google Scholar 

  9. Perrett, K. P., Sindher, S. B., Begin, P., Shanks, J. & Elizur, A. J. Allergy Clin. Immunol. Pract. 10, 19–33 (2022).

    Article  CAS  PubMed  Google Scholar 

  10. Leung, D. Y. P. et al. N. Engl. J. Med. 348, 986–993 (2003).

    Article  CAS  PubMed  Google Scholar 

  11. Zuberbier, T. J. Allergy Clin. Immunol. Pract. 11, 1134–1146 (2023).

    Article  CAS  Google Scholar 

  12. Hwang, D. W., Nagler, C. R. & Ciaccio, C. E. Immunother. Adv. 2, ltac006 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

K.P.P. is supported by a National Health and Medical Research Council (Australia) fellowship (GNT2008911) and a Melbourne Children’s Clinician–Scientist Fellowship. Research at Murdoch Children’s Research Institute is supported by the Victorian Government’s Operational Infrastructure Support Program.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kirsten P. Perrett.

Ethics declarations

Competing interests

K.P.P. has received research grants from Aravax, DBV Technologies, Novartis and Siolta and consultant fees from Aravax, paid to their institution, outside the submitted work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perrett, K.P. The hype and hope of new food allergy treatments. Nat Med (2024). https://doi.org/10.1038/s41591-024-02952-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41591-024-02952-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing